Anticancer drug, also called antineoplastic drug, any drug that is effective in the treatment of malignant, or cancerous, disease. There are several major classes of anticancer drugs; these include alkylating agents, antimetabolites, natural products, and hormones.
Scope of the Report:
This report focuses on the Anti-Cancer Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
China and India are expected to offer good opportunities an account of improvement in healthcare infrastructure. In Africa, industry is expected to drive at lower rate on account of lack of healthcare infrastructure, expensive medical services and lack of consumer awareness.
Central & South America is expected to drive at stable rates on account of costly medicines coupled with minimal awareness initiatives by regional government. Global market is also expected to have legal conflicts arising on account of patents which in turn are expected to negatively impact overall industry.
The worldwide market for Anti-Cancer Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Merck
- Bristol-Myers Squibb
- Bayer
- GlaxoSmithKline
- Novartis
- Sanofi
- Pfizer
- Amgen
- Celgene Corporation
- Ariad Pharmaceuticals
- Eli Lilly
- Hoffmann-La Roche Ltd.
- AstraZeneca
- Boehringer Ingelheim GmbH
- Teva Pharmaceuticals
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Avastin
- Rituxan
- Herceptin
- Alimta
Market Segment by Applications, can be divided into
- Hospital
- Clinic
- Home Care
There are 15 Chapters to deeply display the global Anti-Cancer Drug market.
Chapter 1, to describe Anti-Cancer Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Anti-Cancer Drug, with sales, revenue, and price of Anti-Cancer Drug, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Anti-Cancer Drug, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Anti-Cancer Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Anti-Cancer Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Anti-Cancer Drug Market 2018, Forecast to 2023
Table of Contents
1 Market Overview
1.1 Anti-Cancer Drug Introduction
1.2 Market Analysis by Type
1.2.1 Avastin
1.2.2 Rituxan
1.2.3 Herceptin
1.2.4 Alimta
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Home Care
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Business Overview
2.1.1.1 Merck Description
2.1.1.2 Merck Headquarter, Main Business and Finance Overview
2.1.2 Merck Anti-Cancer Drug Product Introduction
2.1.2.1 Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
2.1.2.2 Anti-Cancer Drug Product Information
2.1.3 Merck Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Merck Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Merck Anti-Cancer Drug Market Share in 2017
2.2 Bristol-Myers Squibb
2.2.1 Business Overview
2.2.1.1 Bristol-Myers Squibb Description
2.2.1.2 Bristol-Myers Squibb Headquarter, Main Business and Finance Overview
2.2.2 Bristol-Myers Squibb Anti-Cancer Drug Product Introduction
2.2.2.1 Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
2.2.2.2 Anti-Cancer Drug Product Information
2.2.3 Bristol-Myers Squibb Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Bristol-Myers Squibb Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Bristol-Myers Squibb Anti-Cancer Drug Market Share in 2017
2.3 Bayer
2.3.1 Business Overview
2.3.1.1 Bayer Description
2.3.1.2 Bayer Headquarter, Main Business and Finance Overview
2.3.2 Bayer Anti-Cancer Drug Product Introduction
2.3.2.1 Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
2.3.2.2 Anti-Cancer Drug Product Information
2.3.3 Bayer Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Bayer Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Bayer Anti-Cancer Drug Market Share in 2017
2.4 GlaxoSmithKline
2.4.1 Business Overview
2.4.1.1 GlaxoSmithKline Description
2.4.1.2 GlaxoSmithKline Headquarter, Main Business and Finance Overview
2.4.2 GlaxoSmithKline Anti-Cancer Drug Product Introduction
2.4.2.1 Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
2.4.2.2 Anti-Cancer Drug Product Information
2.4.3 GlaxoSmithKline Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 GlaxoSmithKline Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global GlaxoSmithKline Anti-Cancer Drug Market Share in 2017
2.5 Novartis
2.5.1 Business Overview
2.5.1.1 Novartis Description
2.5.1.2 Novartis Headquarter, Main Business and Finance Overview
2.5.2 Novartis Anti-Cancer Drug Product Introduction
2.5.2.1 Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
2.5.2.2 Anti-Cancer Drug Product Information
2.5.3 Novartis Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Novartis Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Novartis Anti-Cancer Drug Market Share in 2017
2.6 Sanofi
2.6.1 Business Overview
2.6.1.1 Sanofi Description
2.6.1.2 Sanofi Headquarter, Main Business and Finance Overview
2.6.2 Sanofi Anti-Cancer Drug Product Introduction
2.6.2.1 Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
2.6.2.2 Anti-Cancer Drug Product Information
2.6.3 Sanofi Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Sanofi Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Sanofi Anti-Cancer Drug Market Share in 2017
2.7 Pfizer
2.7.1 Business Overview
2.7.1.1 Pfizer Description
2.7.1.2 Pfizer Headquarter, Main Business and Finance Overview
2.7.2 Pfizer Anti-Cancer Drug Product Introduction
2.7.2.1 Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
2.7.2.2 Anti-Cancer Drug Product Information
2.7.3 Pfizer Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Pfizer Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Pfizer Anti-Cancer Drug Market Share in 2017
2.8 Amgen
2.8.1 Business Overview
2.8.1.1 Amgen Description
2.8.1.2 Amgen Headquarter, Main Business and Finance Overview
2.8.2 Amgen Anti-Cancer Drug Product Introduction
2.8.2.1 Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
2.8.2.2 Anti-Cancer Drug Product Information
2.8.3 Amgen Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Amgen Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Amgen Anti-Cancer Drug Market Share in 2017
2.9 Celgene Corporation
2.9.1 Business Overview
2.9.1.1 Celgene Corporation Description
2.9.1.2 Celgene Corporation Headquarter, Main Business and Finance Overview
2.9.2 Celgene Corporation Anti-Cancer Drug Product Introduction
2.9.2.1 Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
2.9.2.2 Anti-Cancer Drug Product Information
2.9.3 Celgene Corporation Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Celgene Corporation Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Celgene Corporation Anti-Cancer Drug Market Share in 2017
2.10 Ariad Pharmaceuticals
2.10.1 Business Overview
2.10.1.1 Ariad Pharmaceuticals Description
2.10.1.2 Ariad Pharmaceuticals Headquarter, Main Business and Finance Overview
2.10.2 Ariad Pharmaceuticals Anti-Cancer Drug Product Introduction
2.10.2.1 Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
2.10.2.2 Anti-Cancer Drug Product Information
2.10.3 Ariad Pharmaceuticals Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Ariad Pharmaceuticals Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Ariad Pharmaceuticals Anti-Cancer Drug Market Share in 2017
2.11 Eli Lilly
2.11.1 Business Overview
2.11.2 Eli Lilly Anti-Cancer Drug Product Introduction
2.11.3 Eli Lilly Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Hoffmann-La Roche Ltd.
2.12.1 Business Overview
2.12.2 Hoffmann-La Roche Ltd. Anti-Cancer Drug Product Introduction
2.12.3 Hoffmann-La Roche Ltd. Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 AstraZeneca
2.13.1 Business Overview
2.13.2 AstraZeneca Anti-Cancer Drug Product Introduction
2.13.3 AstraZeneca Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Boehringer Ingelheim GmbH
2.14.1 Business Overview
2.14.2 Boehringer Ingelheim GmbH Anti-Cancer Drug Product Introduction
2.14.3 Boehringer Ingelheim GmbH Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Teva Pharmaceuticals
2.15.1 Business Overview
2.15.2 Teva Pharmaceuticals Anti-Cancer Drug Product Introduction
2.15.3 Teva Pharmaceuticals Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Anti-Cancer Drug Market Competition, by Manufacturer
3.1 Global Anti-Cancer Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Anti-Cancer Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Anti-Cancer Drug Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Anti-Cancer Drug Manufacturer Market Share in 2017
3.4.2 Top 5 Anti-Cancer Drug Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Anti-Cancer Drug Market Analysis by Regions
4.1 Global Anti-Cancer Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Anti-Cancer Drug Sales by Regions (2013-2018)
4.1.2 Global Anti-Cancer Drug Revenue by Regions (2013-2018)
4.2 North America Anti-Cancer Drug Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Anti-Cancer Drug Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Anti-Cancer Drug Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Anti-Cancer Drug Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Anti-Cancer Drug Sales, Revenue and Growth Rate (2013-2018)
5 North America Anti-Cancer Drug by Countries, Type, Application and Manufacturers
5.1 North America Anti-Cancer Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Anti-Cancer Drug Sales by Countries (2013-2018)
5.1.2 North America Anti-Cancer Drug Revenue by Countries (2013-2018)
5.1.3 United States Anti-Cancer Drug Sales and Growth Rate (2013-2018)
5.1.4 Canada Anti-Cancer Drug Sales and Growth Rate (2013-2018)
5.1.5 Mexico Anti-Cancer Drug Sales and Growth Rate (2013-2018)
5.2 North America Anti-Cancer Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Anti-Cancer Drug Sales by Manufacturers (2016-2017)
5.2.2 North America Anti-Cancer Drug Revenue by Manufacturers (2016-2017)
5.3 North America Anti-Cancer Drug Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Anti-Cancer Drug Sales and Sales Share by Type (2013-2018)
5.3.2 North America Anti-Cancer Drug Revenue and Revenue Share by Type (2013-2018)
5.4 North America Anti-Cancer Drug Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Anti-Cancer Drug Sales and Sales Share by Application (2013-2018)
5.4.2 North America Anti-Cancer Drug Revenue and Revenue Share by Application (2013-2018)
6 Europe Anti-Cancer Drug by Countries, Type, Application and Manufacturers
6.1 Europe Anti-Cancer Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Anti-Cancer Drug Sales by Countries (2013-2018)
6.1.2 Europe Anti-Cancer Drug Revenue by Countries (2013-2018)
6.1.3 Germany Anti-Cancer Drug Sales and Growth Rate (2013-2018)
6.1.4 UK Anti-Cancer Drug Sales and Growth Rate (2013-2018)
6.1.5 France Anti-Cancer Drug Sales and Growth Rate (2013-2018)
6.1.6 Russia Anti-Cancer Drug Sales and Growth Rate (2013-2018)
6.1.7 Italy Anti-Cancer Drug Sales and Growth Rate (2013-2018)
6.2 Europe Anti-Cancer Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Anti-Cancer Drug Sales by Manufacturers (2016-2017)
6.2.2 Europe Anti-Cancer Drug Revenue by Manufacturers (2016-2017)
6.3 Europe Anti-Cancer Drug Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Anti-Cancer Drug Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Anti-Cancer Drug Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Anti-Cancer Drug Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Anti-Cancer Drug Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Anti-Cancer Drug Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Anti-Cancer Drug by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Anti-Cancer Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Anti-Cancer Drug Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Anti-Cancer Drug Revenue by Countries (2013-2018)
7.1.3 China Anti-Cancer Drug Sales and Growth Rate (2013-2018)
7.1.4 Japan Anti-Cancer Drug Sales and Growth Rate (2013-2018)
7.1.5 Korea Anti-Cancer Drug Sales and Growth Rate (2013-2018)
7.1.6 India Anti-Cancer Drug Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Anti-Cancer Drug Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Anti-Cancer Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Anti-Cancer Drug Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Anti-Cancer Drug Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Anti-Cancer Drug Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Anti-Cancer Drug Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Anti-Cancer Drug Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Anti-Cancer Drug Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Anti-Cancer Drug Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Anti-Cancer Drug Revenue and Revenue Share by Application (2013-2018)
8 South America Anti-Cancer Drug by Countries, Type, Application and Manufacturers
8.1 South America Anti-Cancer Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Anti-Cancer Drug Sales by Countries (2013-2018)
8.1.2 South America Anti-Cancer Drug Revenue by Countries (2013-2018)
8.1.3 Brazil Anti-Cancer Drug Sales and Growth Rate (2013-2018)
8.1.4 Argentina Anti-Cancer Drug Sales and Growth Rate (2013-2018)
8.1.5 Colombia Anti-Cancer Drug Sales and Growth Rate (2013-2018)
8.2 South America Anti-Cancer Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Anti-Cancer Drug Sales by Manufacturers (2016-2017)
8.2.2 South America Anti-Cancer Drug Revenue by Manufacturers (2016-2017)
8.3 South America Anti-Cancer Drug Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Anti-Cancer Drug Sales and Sales Share by Type (2013-2018)
8.3.2 South America Anti-Cancer Drug Revenue and Revenue Share by Type (2013-2018)
8.4 South America Anti-Cancer Drug Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Anti-Cancer Drug Sales and Sales Share by Application (2013-2018)
8.4.2 South America Anti-Cancer Drug Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Anti-Cancer Drug by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Anti-Cancer Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Anti-Cancer Drug Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Anti-Cancer Drug Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Anti-Cancer Drug Sales and Growth Rate (2013-2018)
9.1.4 UAE Anti-Cancer Drug Sales and Growth Rate (2013-2018)
9.1.5 Egypt Anti-Cancer Drug Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Anti-Cancer Drug Sales and Growth Rate (2013-2018)
9.1.7 South Africa Anti-Cancer Drug Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Anti-Cancer Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Anti-Cancer Drug Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Anti-Cancer Drug Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Anti-Cancer Drug Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Anti-Cancer Drug Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Anti-Cancer Drug Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Anti-Cancer Drug Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Anti-Cancer Drug Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Anti-Cancer Drug Revenue and Revenue Share by Application (2013-2018)
10 Global Anti-Cancer Drug Market Segment by Type
10.1 Global Anti-Cancer Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Anti-Cancer Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Anti-Cancer Drug Revenue and Market Share by Type (2013-2018)
10.2 Avastin Sales Growth and Price
10.2.1 Global Avastin Sales Growth (2013-2018)
10.2.2 Global Avastin Price (2013-2018)
10.3 Rituxan Sales Growth and Price
10.3.1 Global Rituxan Sales Growth (2013-2018)
10.3.2 Global Rituxan Price (2013-2018)
10.4 Herceptin Sales Growth and Price
10.4.1 Global Herceptin Sales Growth (2013-2018)
10.4.2 Global Herceptin Price (2013-2018)
10.5 Alimta Sales Growth and Price
10.5.1 Global Alimta Sales Growth (2013-2018)
10.5.2 Global Alimta Price (2013-2018)
11 Global Anti-Cancer Drug Market Segment by Application
11.1 Global Anti-Cancer Drug Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Clinic Sales Growth (2013-2018)
11.4 Home Care Sales Growth (2013-2018)
12 Anti-Cancer Drug Market Forecast (2018-2023)
12.1 Global Anti-Cancer Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Anti-Cancer Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Anti-Cancer Drug Market Forecast (2018-2023)
12.2.2 Europe Anti-Cancer Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Anti-Cancer Drug Market Forecast (2018-2023)
12.2.4 South America Anti-Cancer Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Anti-Cancer Drug Market Forecast (2018-2023)
12.3 Anti-Cancer Drug Market Forecast by Type (2018-2023)
12.3.1 Global Anti-Cancer Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Anti-Cancer Drug Market Share Forecast by Type (2018-2023)
12.4 Anti-Cancer Drug Market Forecast by Application (2018-2023)
12.4.1 Global Anti-Cancer Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Anti-Cancer Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Anti-Cancer Drug Picture
Table Product Specifications of Anti-Cancer Drug
Figure Global Anti-Cancer Drug CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Anti-Cancer Drug CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Anti-Cancer Drug by Types in 2017
Figure Avastin Picture
Table Major Manufacturers of Avastin
Figure Rituxan Picture
Table Major Manufacturers of Rituxan
Figure Herceptin Picture
Table Major Manufacturers of Herceptin
Figure Alimta Picture
Table Major Manufacturers of Alimta
Figure Anti-Cancer Drug Sales Market Share by Applications in 2017
Figure Hospital Picture
Figure Clinic Picture
Figure Home Care Picture
Figure United States Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure France Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure UK Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure China Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure India Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Anti-Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Table Merck Headquarter, Established, Main Business and Finance Overview (2017)
Table Merck Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
Table Merck Anti-Cancer Drug Product
Table Merck Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Merck Anti-Cancer Drug Sales Market Share in 2017
Figure Global Merck Anti-Cancer Drug Revenue Market Share in 2017
Table Bristol-Myers Squibb Headquarter, Established, Main Business and Finance Overview (2017)
Table Bristol-Myers Squibb Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
Table Bristol-Myers Squibb Anti-Cancer Drug Product
Table Bristol-Myers Squibb Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Bristol-Myers Squibb Anti-Cancer Drug Sales Market Share in 2017
Figure Global Bristol-Myers Squibb Anti-Cancer Drug Revenue Market Share in 2017
Table Bayer Headquarter, Established, Main Business and Finance Overview (2017)
Table Bayer Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
Table Bayer Anti-Cancer Drug Product
Table Bayer Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Bayer Anti-Cancer Drug Sales Market Share in 2017
Figure Global Bayer Anti-Cancer Drug Revenue Market Share in 2017
Table GlaxoSmithKline Headquarter, Established, Main Business and Finance Overview (2017)
Table GlaxoSmithKline Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
Table GlaxoSmithKline Anti-Cancer Drug Product
Table GlaxoSmithKline Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global GlaxoSmithKline Anti-Cancer Drug Sales Market Share in 2017
Figure Global GlaxoSmithKline Anti-Cancer Drug Revenue Market Share in 2017
Table Novartis Headquarter, Established, Main Business and Finance Overview (2017)
Table Novartis Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
Table Novartis Anti-Cancer Drug Product
Table Novartis Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novartis Anti-Cancer Drug Sales Market Share in 2017
Figure Global Novartis Anti-Cancer Drug Revenue Market Share in 2017
Table Sanofi Headquarter, Established, Main Business and Finance Overview (2017)
Table Sanofi Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
Table Sanofi Anti-Cancer Drug Product
Table Sanofi Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sanofi Anti-Cancer Drug Sales Market Share in 2017
Figure Global Sanofi Anti-Cancer Drug Revenue Market Share in 2017
Table Pfizer Headquarter, Established, Main Business and Finance Overview (2017)
Table Pfizer Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
Table Pfizer Anti-Cancer Drug Product
Table Pfizer Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Pfizer Anti-Cancer Drug Sales Market Share in 2017
Figure Global Pfizer Anti-Cancer Drug Revenue Market Share in 2017
Table Amgen Headquarter, Established, Main Business and Finance Overview (2017)
Table Amgen Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
Table Amgen Anti-Cancer Drug Product
Table Amgen Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Amgen Anti-Cancer Drug Sales Market Share in 2017
Figure Global Amgen Anti-Cancer Drug Revenue Market Share in 2017
Table Celgene Corporation Headquarter, Established, Main Business and Finance Overview (2017)
Table Celgene Corporation Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
Table Celgene Corporation Anti-Cancer Drug Product
Table Celgene Corporation Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Celgene Corporation Anti-Cancer Drug Sales Market Share in 2017
Figure Global Celgene Corporation Anti-Cancer Drug Revenue Market Share in 2017
Table Ariad Pharmaceuticals Headquarter, Established, Main Business and Finance Overview (2017)
Table Ariad Pharmaceuticals Anti-Cancer Drug Production Bases, Sales Regions and Major Competitors
Table Ariad Pharmaceuticals Anti-Cancer Drug Product
Table Ariad Pharmaceuticals Anti-Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Ariad Pharmaceuticals Anti-Cancer Drug Sales Market Share in 2017
Figure Global Ariad Pharmaceuticals Anti-Cancer Drug Revenue Market Share in 2017
Table Eli Lilly
Table Eli Lilly Anti-Cancer Drug
Table Hoffmann-La Roche Ltd.
Table Hoffmann-La Roche Ltd. Anti-Cancer Drug
Table AstraZeneca
Table AstraZeneca Anti-Cancer Drug
Table Boehringer Ingelheim GmbH
Table Boehringer Ingelheim GmbH Anti-Cancer Drug
Table Teva Pharmaceuticals
Table Teva Pharmaceuticals Anti-Cancer Drug
Table Global Anti-Cancer Drug Sales by Manufacturer (2016-2017)
Figure Global Anti-Cancer Drug Sales Market Share by Manufacturer in 2016
Figure Global Anti-Cancer Drug Sales Market Share by Manufacturer in 2017
Table Global Anti-Cancer Drug Revenue by Manufacturer (2016-2017)
Figure Global Anti-Cancer Drug Revenue Market Share by Manufacturer in 2016
Figure Global Anti-Cancer Drug Revenue Market Share by Manufacturer in 2017
Table Global Anti-Cancer Drug Price by Manufacturer (2016-2017)
Figure Top 3 Anti-Cancer Drug Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Anti-Cancer Drug Manufacturer (Revenue) Market Share in 2017
Figure Global Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure Global Anti-Cancer Drug Revenue and Growth Rate (2013-2018)
Table Global Anti-Cancer Drug Sales by Regions (2013-2018)
Table Global Anti-Cancer Drug Sales Market Share by Regions (2013-2018)
Table Global Anti-Cancer Drug Revenue by Regions (2013-2018)
Figure Global Anti-Cancer Drug Revenue Market Share by Regions in 2013
Figure Global Anti-Cancer Drug Revenue Market Share by Regions in 2017
Figure North America Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure North America Anti-Cancer Drug Revenue and Growth Rate (2013-2018)
Figure Europe Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure Europe Anti-Cancer Drug Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Anti-Cancer Drug Revenue and Growth Rate (2013-2018)
Figure South America Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure South America Anti-Cancer Drug Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Anti-Cancer Drug Revenue and Growth Rate (2013-2018)
Figure North America Anti-Cancer Drug Revenue and Growth Rate (2013-2018)
Table North America Anti-Cancer Drug Sales by Countries (2013-2018)
Table North America Anti-Cancer Drug Sales Market Share by Countries (2013-2018)
Figure North America Anti-Cancer Drug Sales Market Share by Countries in 2013
Figure North America Anti-Cancer Drug Sales Market Share by Countries in 2017
Table North America Anti-Cancer Drug Revenue by Countries (2013-2018)
Table North America Anti-Cancer Drug Revenue Market Share by Countries (2013-2018)
Figure North America Anti-Cancer Drug Revenue Market Share by Countries in 2013
Figure North America Anti-Cancer Drug Revenue Market Share by Countries in 2017
Figure United States Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure Canada Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure Mexico Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Table North America Anti-Cancer Drug Sales by Manufacturer (2016-2017)
Figure North America Anti-Cancer Drug Sales Market Share by Manufacturer in 2016
Figure North America Anti-Cancer Drug Sales Market Share by Manufacturer in 2017
Table North America Anti-Cancer Drug Revenue by Manufacturer (2016-2017)
Figure North America Anti-Cancer Drug Revenue Market Share by Manufacturer in 2016
Figure North America Anti-Cancer Drug Revenue Market Share by Manufacturer in 2017
Table North America Anti-Cancer Drug Sales by Type (2013-2018)
Table North America Anti-Cancer Drug Sales Share by Type (2013-2018)
Table North America Anti-Cancer Drug Revenue by Type (2013-2018)
Table North America Anti-Cancer Drug Revenue Share by Type (2013-2018)
Table North America Anti-Cancer Drug Sales by Application (2013-2018)
Table North America Anti-Cancer Drug Sales Share by Application (2013-2018)
Table North America Anti-Cancer Drug Revenue by Application (2013-2018)
Table North America Anti-Cancer Drug Revenue Share by Application (2013-2018)
Figure Europe Anti-Cancer Drug Revenue and Growth Rate (2013-2018)
Table Europe Anti-Cancer Drug Sales by Countries (2013-2018)
Table Europe Anti-Cancer Drug Sales Market Share by Countries (2013-2018)
Table Europe Anti-Cancer Drug Revenue by Countries (2013-2018)
Figure Europe Anti-Cancer Drug Revenue Market Share by Countries in 2016
Figure Europe Anti-Cancer Drug Revenue Market Share by Countries in 2017
Figure Germany Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure UK Anti-Cancer Drug Sales and Growth Rate (2013-2018)
Figure Fran
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
